ArticleMolecular cancer2014

Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.

Kelie M Reece et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.